000739 普洛药业
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)3.86113.61915.90717.98718.713
总资产报酬率 ROA (%)2.0277.1128.0888.5159.391
投入资产回报率 ROIC (%)2.5448.92410.29410.81311.717

边际利润分析
销售毛利率 (%)29.30426.35723.84525.66423.904
营业利润率 (%)12.14710.94510.08210.6349.593
息税前利润/营业总收入 (%)13.41510.2979.0519.5898.595
净利润/营业总收入 (%)10.1859.1048.5759.1979.381

收益指标分析
经营活动净收益/利润总额(%)105.65393.27996.641103.197106.358
价值变动净收益/利润总额(%)-0.6311.855-0.842-1.802-8.162
营业外收支净额/利润总额(%)0.180-0.438-0.730-1.2870.044

偿债能力分析
流动比率 (X)1.5531.4691.4261.3271.291
速动比率 (X)1.2791.1701.1020.9960.992
资产负债率 (%)46.37548.48046.97251.20254.088
带息债务/全部投入资本 (%)31.49633.90432.02234.81740.543
股东权益/带息债务 (%)212.991190.779207.175181.084140.879
股东权益/负债合计 (%)115.491106.137112.75895.18984.771
利息保障倍数 (X)10.766-17.146-9.448-10.542-8.570

营运能力分析
应收账款周转天数 (天)68.57763.98551.79452.77153.180
存货周转天数 (天)77.79186.49077.53181.98868.455